SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001962738-24-000004
Filing Date
2024-02-29
Accepted
2024-02-29 16:14:09
Documents
1
Period of Report
2024-02-29

Document Format Files

Seq Description Document Type Size
1 6-K tmb-20240229x6k.htm 6-K 15822
  Complete submission text file 0001962738-24-000004.txt   17103
Mailing Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025
Business Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025 86 10 6561 8789
CASI Pharmaceuticals, Inc. (Filer) CIK: 0001962738 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41666 | Film No.: 24703813
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)